Viewing Study NCT05394493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-29 @ 5:09 PM
Study NCT ID: NCT05394493
Status: COMPLETED
Last Update Posted: 2023-12-06
First Post: 2022-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Renal Cell Carcinoma View
Keywords: